Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene. - Wikidata - awgldk - TriplyDB

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

http://www.wikidata.org/entity/Q41602005

about

H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis The Polycomb group protein EZH2 impairs DNA repair in breast epithelial cells A review of the past, present, and future directions of neoplasia Coming of Age in the Life of Potential epigenetic mechanism(s) associated with the persistence of psychoneurological symptoms in women receiving chemotherapy for breast cancer: a hypothesis Polycomb silencers control cell fate, development and cancer Consistent expression of the stem cell renewal factor BMI-1 in primary and metastatic melanoma.Expression of polycomb group protein EZH2 in nevi and melanoma.Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma.Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS Dietary omega-3 polyunsaturated fatty acids suppress expression of EZH2 in breast cancer cells.Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines Down-regulation of miR-101 in endothelial cells promotes blood vessel formation through reduced repression of EZH2 Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer.Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma.Gene expression and DNA-methylation of bovine pretransfer endometrium depending on its receptivity after in vitro-produced embryo transfer.Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer.Increased expression of EZH2, a polycomb group protein, in bladder carcinoma.Mutations in the extra sex combs and Enhancer of Polycomb genes increase homologous recombination in somatic cells of Drosophila melanogaster Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.The role of nuclear organization in cancer.EZH2 and ALDH-1 mark breast epithelium at risk for breast cancer development.The transcriptional repressor ZBTB4 regulates EZH2 through a MicroRNA-ZBTB4-specificity protein signaling axis In utero exposure to diethylstilbestrol (DES) or bisphenol-A (BPA) increases EZH2 expression in the mammary gland: an epigenetic mechanism linking endocrine disruptors to breast cancer Histone methylases as novel drug targets: developing inhibitors of EZH2.Connections between epigenetic gene silencing and human disease.Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression Significance of EZH2 expression in canine mammary tumors.Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma.A systematic analysis of miRNA transcriptome in Marek's disease virus-induced lymphoma reveals novel and differentially expressed miRNAs.The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma.Implication of abnormal epigenetic patterns for human diseases.Role of several histone lysine methyltransferases in tumor development.Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.Enhancer of zeste homologue 2 (EZH2) down-regulates RUNX3 by increasing histone H3 methylation.High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer

P2860

Q24322697-8B5F5248-9E40-4707-8908-38E1BDC69912 Q24528253-363982AD-7368-40DF-B53D-1325E92A018D Q24604354-4A5B4E0D-BD60-46A9-95F1-AAE0BA751B66 Q28285316-6D5CD30E-273F-460F-A7F8-BF3B26EFE64A Q28389391-91131ED0-C7E6-4D1A-9122-9979394DCA6A Q28389985-9855CC97-737C-4778-9C7F-EA677F10A832 Q28393302-6A2101F8-8DDC-45A5-8342-4EFC8CDDD48A Q29619697-1FC778BE-D3D4-4881-ABC3-721D7B438E6B Q33289108-9AA8E0FD-33E8-425D-8F5B-192A5A4F482C Q33291217-1A4D2876-07F2-4E65-8C23-AD32EC4E5300 Q33293121-617B93C0-3359-4249-A7BE-D9AE8594ACEF Q33592489-B6CCCA21-1097-4332-B175-3A2FB5144690 Q33705232-549EB8E3-EC6B-4DE6-BEE4-38A64B04624F Q33709689-E83EC31D-1C62-429D-A604-1DDE5A61B944 Q33766326-5E8AAA82-C76A-4AB5-903C-74AF191A61CC Q33813030-CE20D1B5-F586-4942-810B-04E7556ECA73 Q34328025-50AEAB21-7B50-4EDF-839B-4D6E3E243F34 Q34360544-296EA9FB-6C33-4762-8ECE-1D2E30B7B95E Q34404719-D186B226-8455-4902-9A19-DF90060BD935 Q34409667-412898A7-404F-4190-90BA-C829462792E5 Q34458323-4648630F-3857-4697-8CA1-14E49E125C39 Q34588653-D2C41471-0333-45BF-B239-4389AA90E13B Q34928738-01C53469-CF58-4414-ABC5-7431A4C642A6 Q35013829-39B49E1B-E44A-492A-8A5D-588937A8A97A Q35019505-03D12B8D-837E-407A-A3A6-DAEBF1199D37 Q35022495-0978D05D-0B7A-40FD-97FC-158FAE52B2A3 Q35116862-5B7A9828-8733-4DD1-9147-F67FB3CAD07A Q35510392-1CD0F1CE-90A8-40CB-B563-13F527B3499E Q35843804-171E84F6-4669-49A4-80C5-CFAD28A70296 Q35849140-DCB3CA15-43F2-4717-9A08-F14A3D454F5E Q36098022-9DB6A28D-0252-47B5-880B-67789D9706F1 Q36105152-903DBC3F-9881-4CB5-BA33-1887B2A60ABB Q36437698-8A0002D6-6679-4ED3-BDC5-4A6D850B28C5 Q36611909-3D1BD0E5-50AA-48F9-B93B-E090B8F8A5E8 Q36616798-8A5676D6-E3E2-4BB7-8FD1-5EB3FA10C863 Q36626596-631A654B-1E9C-4C6B-937E-F8F6E387ED3F Q36639797-7FB8C96C-18BB-49A4-BBC1-83A728D227A2 Q36667455-7B90C273-3AF8-45BB-9F1F-FA44DD1C8D37 Q36719239-F209E21F-1518-4C2D-9BB4-34CCB85B2DD6 Q36768995-A8A26B2C-B792-4B2B-9CCE-A8FF80C8BF18

P2860

Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.

http://www.wikidata.org/entity/Q41602005

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Poorly differentiated breast c ...... uman polycomb group EZH2 gene.

@en

type

label

Poorly differentiated breast c ...... uman polycomb group EZH2 gene.

@en

prefLabel

Poorly differentiated breast c ...... uman polycomb group EZH2 gene.

@en

P1433

Q41602005-15323BEC-B217-4616-9C38-BEC8F0BD77D9

P1476

Q41602005-F0841936-1E1F-41CF-9FF2-6C292BC97DB5

P2093

Q41602005-07B48B6E-6F25-4B9C-B358-D671C5F8503E

Q41602005-0F86F440-0433-4F01-BA3D-038747A50C0E

Q41602005-508F61D4-7E46-4AF1-8CC1-F488A9EA6619

Q41602005-5BD26DBD-8937-4682-A333-D78320A043F0

Q41602005-6C0ADE1F-42C7-45A1-9B97-D35B8DEE574D

Q41602005-7496B9AD-CF1B-40D6-A325-C5E4B7214FC8

Q41602005-77D707CC-5BBE-48BC-AAFA-C1D32520642B

Q41602005-7F03A3DB-72F6-4561-BFA1-9CD0419B93A7

Q41602005-B21D3075-7EFF-48B9-AEAE-C633EFD2C569

Q41602005-C3A156A1-6675-4F7C-AD54-78C29B46F40D

P2860

Q41602005-09BECF4C-4AD9-4135-ADD0-72B36AC775AC

Q41602005-0EB46D21-B31B-46F3-83C4-3E8237ECCF08

Q41602005-107532BE-F41F-46A0-8D33-ECC6773A3DEC

Q41602005-16D96E63-9351-4D83-804D-418841816B51

Q41602005-1823D06A-9FC3-45BA-9AF2-6E4BFAC3F426

Q41602005-1C30E779-D8CA-48D1-88A9-C3B9CEEC9698

Q41602005-250DC039-327F-420D-BD5A-56ADB15D6012

Q41602005-28C6931F-0405-4037-BA1E-24F8752CE29A

Q41602005-29A6368E-1AAF-4991-BE58-EBDDD69F8B72

Q41602005-307AB948-7AC4-4855-A85A-01758931FED1

P304

Q41602005-077A5106-A905-4DBC-9F41-74DCEC348548

P31

Q41602005-92CCD9E9-0BA7-4E24-9821-4BD5EB4BBF54

P356

Q41602005-5269F483-53B6-41AC-8054-77CA74FFC7A4

P433

Q41602005-E8B5D9F6-0E51-48E6-B76F-A09B42C4E18E

P478

Q41602005-61070729-279B-415C-A306-383A5EB2E561

P577

Q41602005-850A05E6-5056-4168-A5EA-9AE04B0593DF

P5875

Q41602005-CCCD1D52-8DFB-49AD-848D-B67F3257B78E

P698

Q41602005-36A2CB37-F027-4E9B-BA95-6B6E45C5B4D2

P932

Q41602005-7B998F7C-6F30-4AFE-BE11-E2C749D325D3

P356

S1476-5586(03)80032-5

P1433

P1476

Poorly differentiated breast c ...... uman polycomb group EZH2 gene.

@en

P2093

Arie P Otte

http://www.w3.org/2001/XMLSchema#string

Chris J L M Meijer

http://www.w3.org/2001/XMLSchema#string

Ellen Mommers

http://www.w3.org/2001/XMLSchema#string

Elly Fieret

http://www.w3.org/2001/XMLSchema#string

Frank M Raaphorst

http://www.w3.org/2001/XMLSchema#string

Horst Buerger

http://www.w3.org/2001/XMLSchema#string

Jens Packeisen

http://www.w3.org/2001/XMLSchema#string

Paul J van Diest

http://www.w3.org/2001/XMLSchema#string

Richard A B Sewalt

http://www.w3.org/2001/XMLSchema#string

Tjasso Blokzijl

http://www.w3.org/2001/XMLSchema#string

P2860

The Drosophila Polycomb Group proteins ESC and E(Z) are present in a complex containing the histone-binding protein p55 and the histone deacetylase RPD3

The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans.

RING1 is associated with the polycomb group protein complex and acts as a transcriptional repressor

Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes.

Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis

Interaction of mouse polycomb-group (Pc-G) proteins Enx1 and Enx2 with Eed: indication for separate Pc-G complexes.

The Drosophila esc and E(z) proteins are direct partners in polycomb group-mediated repression.

The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos

RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity

Identification and characterization of interactions between the vertebrate polycomb-group protein BMI1 and human homologs of polyhomeotic

P304

481-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1476-5586(03)80032-5

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2003-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5687183

http://www.w3.org/2001/XMLSchema#string

P698

14965441

http://www.w3.org/2001/XMLSchema#string

P932

1502571

http://www.w3.org/2001/XMLSchema#string